Sarah is a postdoctoral associate in the Liu Lab, where she is developing high-throughput approaches for creating mutation and gene-agnostic gene therapies. She completed her undergraduate degrees in Neuroscience and Molecular and Cellular Biology at Brown University and her PhD in Cancer Biology at Stanford University. She also spent one year as a Scientist at a start-up company called Eikon Therapeutics before deciding to go back to academia as a postdoc. She has a keen interest in public speaking, initially sparked by participating in four years of competitive policy debate in high school. She is most excited to help individuals with presentations, manuscripts, and fellowship applications.